Hypnotize Away Hot Flashes

Women who don't want to take hormones have limited options in controlling hot flashes for menopause. But one option doesn't involve drugs at all.

Prostate Drug May Lead to Sexual Troubles

Silodosin (Rapaflo) is used to treat enlarged prostate, or benign prostatic hyperplasia (BPH). The drug, however, may trigger an ejaculatory disorder.

Back Pain: Arthritis Within Arthritis

Inflammation is the reason patients with rheumatoid arthritis develop swollen and painful joints. But inflammation is not unique to rheumatoid arthritis; it is also behind other painful joint conditions.

Oral Lice Medicine Works as Lotion

Head lice can be an icky problem for families to deal with. Plus, lice and their eggs are becoming more resistant to typical treatments.

Lasting Relief From Anxiety?

A growing percentage of people experience some sort of anxiety disorder in their lifetime, making treatment options all the more important.

First-Line Diabetes Drug for Your Heart

Diabetes drugs can do wonders for patients' blood sugar. However, those drugs also come with some risks, particularly to the heart. A recent study compared the safety of the two most common diabetes drugs.

Blood Pressure in CKD: An Ethnic Gap

Ethnic minorities are more likely to develop kidney failure than whites. A team of California researchers wondered if poor blood pressure control played a role in this ethnic gap.

Ryzodeg

Ryzodeg is a prescription medication used to treat adults with type 1 and type 2 diabetes. This medication combines an "ultra-long acting" and a rapid-acting insulin that together help keep blood glucose at consistent levels for long periods of time.

Ryzodeg comes as a solution to be injected subcutaneously (just under the skin) once or twice daily, at mealtimes.

The most frequently reported side effect is low blood sugar. Ryzodeg should not be used in those who have increased ketones in their blood or urine (diabetic ketoacidosis).

Serious Crohn's Patients More Fatigued

Nearly two-thirds of patients with long-term major stomach troubles feel tired and weak.

FDA advisory panel recommends approval of long acting insulin

Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has completed its meeting regarding the New Drug Applications (NDA) for insulin degludec and insulin degludec/insulin aspart.

Pages

Subscribe to rxwiki.com RSS